|
2023
|
Invention
|
Use of 2-phenyl-6-(1h-imidazol-1-yl) quinazoline for treating neurodegenerative diseases, prefera... |
|
2022
|
Invention
|
Pharmaceutical combination of an ep4 antagonist and immune checkpoint inhibitors for the treatmen... |
|
2021
|
Invention
|
Process for the preparation of (r)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-ca... |
|
2020
|
Invention
|
New fyn and vegfr2 kinase inhibitors.
The invention relates to a N-phenylcarbamoyl compound of F... |
|
|
Invention
|
(r)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5] octane-5-carboxamido)-cyclopropyl) benzoi... |
|
|
Invention
|
Use of 2-phenyl-6-(1h-imidazol-1-yl) quinazoline for the prevention of abuse and of side effects ... |
|
|
Invention
|
(r)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyclopropyl) benzoic... |
|
|
Invention
|
Use of 2-phenyl-6-(1h-imidazol-1-yl)quinazoline for treating neurodegenerative diseases, preferab... |
|
|
Invention
|
Benzo-and pyrido-pyrazoles as protein kinase inhibitors.
The invention relates to new chemical c... |
|
|
Invention
|
Benzo- and pyrido-pyrazoles as protein kinase inhibitors. The invention relates to new chemical c... |
|
2019
|
Invention
|
New fyn and vegfr2 kinase inhibitors. The invention relates to a N-phenylcarbamoyl compound of Fo... |
|
|
Invention
|
Phenazines as inhibitors of discoidin domain receptors 2 (ddr2). 125653678781343336366)cycloalkyl... |
|
|
Invention
|
(r)-4-(1-(1-(4-(trifluoromethyl)benzyl)pyrrolidine-2-carboxamide)cyclopropyl)-benzoic acid as ep4... |
|
|
Invention
|
Phenazines as inhibitors of discoidin domain receptors 2 (ddr2). 12563677 134 33 13366)cycloalkyl... |
|
2016
|
Invention
|
Anti-trka antibodies, derivatives and uses thereof.
The present invention relates to an antibody... |
|
2015
|
Invention
|
Fyn kinase inhibitors. The invention relates to new selective FYN kinase inhibitors of Formula (I... |
|
|
Invention
|
New fyn kinase inhibitors. The invention relates to new selective FYN kinase inhibitors of Formul... |
|
|
Invention
|
Spiro aminic compounds with nk1 antagonist activity. 3)alkyl and halogen, Y is a substituent sele... |
|
|
Invention
|
Purified cocoa beans extracts, production and use thereof for the treatment of central and periph... |
|
|
Invention
|
Purified cocoa beans and grape seeds extracts, production and use thereof for the treatment of ce... |
|
|
Invention
|
Purified grape seeds extracts, production and use thereof for the treatment of central and periph... |
|
2014
|
P/S
|
chemical and biochemical substances; enzymes; nucleic acid sequences; viral vectors; non-viral ve... |
|
2013
|
Invention
|
Anti-trka antibodies, derivatives and uses thereof. The present invention relates to an antibody,... |
|
|
Invention
|
Anti-adamts-5 antibody, derivatives and uses thereof. The present invention relates to an antibod... |
|
|
Invention
|
2-azabicyclo[4.1.0]heptane derivatives as orexin receptor antagonists for the treatment of certai... |
|
|
Invention
|
Chemical compounds. The present invention provides compounds of formula (I) including stereoisome... |
|
|
Invention
|
4,4-difluoro-piperidine-compounds. The invention, in a first aspect relates to compounds of formu... |
|
2012
|
Invention
|
Chemical compounds. 3; processes for the preparation of those compounds, pharmaceutical compositi... |
|
|
Invention
|
Chemical compounds. The invention relates to a novel compound of formula (I) or a stereoisomer, o... |
|
|
Invention
|
Spiro aminic compounds with nk1 antagonist activity.
The invention concerns a spiro-amino compou... |
|
2011
|
Invention
|
1,5-diary1-2-alkylpyrrole-3-substituted nitro esters, selective cox-2 inhibitors and nitric oxide... |
|
|
Invention
|
Use of neboglamine in the treatment of toxicodependency. Use of neboglamine, (S)-4-amino-N(4,4-di... |
|
|
Invention
|
4 receptor antagonists. 4 receptor antagonistic activity and specifically pharmaceutical compound... |
|
|
Invention
|
4 receptor agonists. 4 receptor agonistic activity.
Specifically, the compounds according to the... |
|
|
Invention
|
6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory ... |
|
2010
|
Invention
|
Pyridine amide derivatives as ep4 receptor antagonists. 2 are independently hydrogen, linear o br... |
|
|
Invention
|
Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction... |
|
|
Invention
|
Crystalline forms of 6-(1h-imidazol-1-yl)-2-phenylquinazoline. The present invention relates to t... |
|
2008
|
Invention
|
Amidine, thiourea and guanidine derivatives of 2-aminobenzothiazoles and aminobenzothiazines for ... |
|
|
Invention
|
6-1h-imidazo-quinazoline and quinolines derivatives, new mao inhibitors and imidazoline receptor ... |
|
|
Invention
|
2-aryl and 2-heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives, new pharmacological agents f... |
|
2006
|
Invention
|
3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective cox-2 inhibitors.... |
